Volumetric analysis of coronary plaque characterization in patients with metabolic syndrome using 64-slice multi-detector computed tomography

Circulation Journal

Volumn 74, Issue 10, 2010, Pages 2146-2151

  Arai, Kosuke ^a,b   Ishii, Hideki ^a   Amano, Tetsuya ^a,b   Uetani, Tadayuki ^a,b   Nanki, Michio ^b   Marui, Nobuyuki ^b   Kato, Masataka ^b   Yokoi, Kiminobu ^b   Ando, Hirohiko ^b   Kumagai, Soichiro ^b   Harada, Ken ^b   Yoshikawa, Daiji ^a   Ohshima, Satoru ^a   Matsubara, Tatsuaki ^c   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHUBU ROSAI HOSPITAL   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Lipid rich plaque; Metabolic syndrome; Multi detector computed tomography

Indexed keywords

LIPID;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY PLAQUE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIDETECTOR COMPUTED TOMOGRAPHY; VOLUMETRY;

AGED; ANGINA PECTORIS; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; REGRESSION ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77958067772     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0219     Document Type: Article

References (33)

1. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
3. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
4. Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: The atherosclerosis risk in communities study. Diabetes 2002; 51: 3069-3076.
5. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL; SMART Study Group. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004; 25: 342-348.
6. Ahluwalia N, Drouet L, Ruidavets JB, Perret B, Amar J, Boccalon H, et al. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 2006; 186: 345-353.
7. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L'Huillier I, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005; 165: 1192-1198.
8. Kawasaki M, Takatsu H, Noda T, Sano K, Ito Y, Hayakawa K, et al. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 2002; 105: 2487-2492.
9. Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M, et al. Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions: Integrated backscatter intravascular ultrasound study. J Am Coll Cardiol 2007; 49: 1149-1156.
10. Sano K, Kawasaki M, Ishihara Y, Okubo M, Tsuchiya K, Nishigaki K, et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2006; 47: 734-741.
11. Jinzaki M, Yamada M, Sato K, Tanami Y, Anzai T, Sasaki K, et al. Overview image of the lumen and vessel wall in coronary CT angiography. Circ J 2008; 72: 671-673.
12. Matsunaga E, Takaya N, Yokoyama T, Akimoto Y, Miyauchi K, Daida H. Relationship between coronary artery wall thickness measured by 64-slice multidetector computed tomography and cardiovascular risk factors. Circ J 2009; 73: 681-685.
13. Achenbach S, Ropers D, Hoffmann U, MacNeill B, Baum U, Pohle K, et al. Assessment of coronary remodeling in stenotic and nonstenotic coronary atherosclerotic lesions by multidetector spiral computed tomography. J Am Coll Cardiol 2004; 43: 842-847.
14. Fuster V, Fayad ZA, Moreno PR, Poon M, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: Part II: Approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol 2005; 46: 1209-1218.
15. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009; 54: 49-57.
16. Oda E, Abe M, Veeraveedu PT, Watanabe K. Considerable disagreement among definitions of metabolic syndrome for Japanese. Circ J 2007; 71: 1239-1243.
17. Kunita E, Fujii T, Urabe Y, Tsujiyama S, Maeda K, Tasaki N, et al. Coronary plaque stabilization followed by Color Code Plaque (TM) analysis with 64-slice multidetector row computed tomography. Circ J 2009; 73: 772-775.
18. Uetani T, Amano T, Kunimura A, Kumagai S, Ando H, Yokoi K, et al. The association between plaque characterization measured by 64-slice multidetector computed tomography and post-procedural myocardial infarction in patients with elective stent implantation. J Am Coll Cardiol Img 2010; 3: 19-28.
19. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993; 69: 377-381.
20. Fernández-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture. J Am Coll Cardiol 1994; 23: 1562-1569.
21. Tartan Z, Ozer N, Uyarel H, Akgul O, Gul M, Cetin M, et al. Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction. Nutr Metab Cardiovasc Dis 2008; 18: 441-447.
22. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
23. Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M, et al. Abnormal glucose regulation is associated with lipid-rich coronary plaque: Relationship to insulin resistance. JACC Cardiovasc Imaging 2008; 1: 39-45.
24. Matsumoto N, Sato Y, Yoda S, Nakano Y, Kunimasa T, Matsuo S, et al. Prognostic value of non-obstructive CT low-dense coronary artery plaques detected by multislice computed tomography. Circ J 2007; 71: 1898-1903.
25. Nakazawa G, Tanabe K, Onuma Y, Yachi S, Aoki J, Yamamoto H, et al. Efficacy of culprit plaque assessment by 64-slice multidetector computed tomography to predict transient no-reflow phenomenon during percutaneous coronary intervention. Am Heart J 2008; 155: 1150-1157.
26. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH study. Circulation 2004; 110: 1061-1068.
27. Kawasaki M, Sano K, Okubo M, Yokoyama H, Ito Y, Murata I, et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005; 45: 1946-1953.
28. Miyagi M, Ishii H, Murakami R, Isobe S, Hayashi M, Amano T, et al. Impact of chronic statin therapy on coronary plaque composition at angiographically severe lesions: A non-randomized study focused on history of chronic statin treatment before coronary angioplasty. Clin Ther 2009; 31: 64-73.
29. Komatsu S, Hirayama A, Omori Y, Ueda Y, Mizote I, Fujisawa Y, et al. Detection of coronary plaque by computed tomography with a novel plaque analysis system, 'Plaque Map', and comparison with intravascular ultrasound and angioscopy. Circ J 2005; 69: 72-77.
30. Choi BJ, Kang DK, Tahk SJ, Choi SY, Yoon MH, Lim HS, et al. Comparison of 64-slice multidetector computed tomography with spectral analysis of intravascular ultrasound backscatter signals for characterizations of noncalcified coronary arterial plaques. Am J Cardiol 2008; 102: 988-993.
31. Hochman JS, Phillips WJ, Ruggieri D, Ryan SF. The distribution of atherosclerotic lesions in the coronary arterial tree: Relation to cardiac risk factors. Am Heart J 1988; 116: 1217-1222.
32. Wang JC, Normand SL, Mauri L, Kuntz RE. Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation 2004; 110: 278-284.
33. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.